Recall Register

Allergan Sales, LLC: FDA recalls

Newest recall start date in this list: . Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only,

FDA enforcement events from 2015 to 2024; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Allergan Sales, LLC as the recalling firm in 8 events. The events have 14 product records. The recalls started from 2015 to 2024. By FDA enforcement events, Allergan Sales, LLC is number 442 of 1,629 firms that have a page. Events that Allergan Sales, LLC started: 1 in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class III is 25.0% of its events and 8.6% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

8 events, newest first.

FDA enforcement events of Allergan Sales, LLC
InitiatedProduct (first record)TypeClassRecordsStatus
14 Mar 2024Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only,DeviceClass II1Ongoing
19 Mar 2019Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05DrugClass II1Terminated
19 Oct 2017Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612..DrugClass III2Terminated
1 May 2017Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.DrugClass II1Terminated
16 Mar 2017Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.DrugClass III1Terminated
30 Jun 2016TAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic Use, packaged in a) 30 g tubes (NDC: 0023-8335-03, UPC: 300238335036) and b)100 g tubes,(NDC: 0023-8335-10, UPC: 300238335104), Manufactured by: Allergan Inc., Irvine, CA 92512.DrugClass II2Terminated
10 May 2016Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612DrugClass II2Terminated
24 Aug 2015Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC 0023-0312-04) UPC 3 0023-0312-04 2 and b) Net wt. 0.25 oz (7 g) tubes (NDC 0023-0312-07) UPC 3 0023-0312-07 3, Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612.DrugClass II4Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Allergan Sales, LLC: events for each product type
TypeEvents
Drug7
Device1
Allergan Sales, LLC: events in each class
ClassEvents
Class II6
Class III2
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
1

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Allergan Sales, LLC, by the year that the recall started. The largest year is 2017, with 3 events.

Official channels

Cite this page

Recall Register. Allergan Sales, LLC: FDA recalls. https://recallregister.com/firm/allergan-sales-llc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
TX, CA

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Allergan Sales, LLC have?
Class II: 6 events. Class III: 2 events. The class is for the product of a recall. It is not a class of the firm.
Which product types do the FDA recalls of Allergan Sales, LLC have?
Drug: 7 events. Device: 1 event.
What is the newest FDA recall of Allergan Sales, LLC?
FDA event 94287, which the firm started on 14 Mar 2024. The first product in the record is: Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only,
How many FDA recalls of Allergan Sales, LLC have the status Ongoing?
1 event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.